×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
概要
April 23: Short Courses
April 24-25: Conference
Labeling is a critical tool for the safe and effective use of prescription drugs, biologics, and medical devices. Its purpose is to convey the essential information needed by providers, patients, and payers to make decisions about product access, prescription, and use. Today’s environment of increasingly complex labeling regulations and guidances is especially challenging for products marketed in multiple regions, which demand worldwide consistency of prescribing and patient information. This Conference provides a forum for regulators and industry to update their knowledge of local and global labeling-related policies and to examine the impact of changes on regulatory compliance. Through expert panels and interactive discussions, participants will share approaches, processes, and tools to ensure effective labeling that meets regulatory expectations.
On-Demand Complimentary Webinar
What is Hot in Global Labeling?This webinar will provide highlights of draft and recently approved regulations for awareness of potential impact to your global operations. This includes the revisions to the EU GVP Module IX guideline, SPL in Canada, updating of labeling in Japan and device regulations in the EU.
Register today!
Five Ws of the Conference
Check out our infographic on the who, what, when, where, and why of the Global Labeling Conference and get a better understanding of how it will impact your day-to-day functions.
View InfographicFeatured Topics
- Global Labeling Issues and Updates
- Labeling Role
- Pharmacovigilance Risk Assessment
- Packaging Issues
- Combination Products
- Biosimilars
- Patient Leaflet
- Plain Language Labeling
- Patient Medication Information (PMI)
- International Strategic Plan
プログラム委員会
-
Steven Bass, PhD President
United States -
Su-Yueh Lin Sr. Labeling Consultant, Regulatory Affairs
SYL Regulatory Consulting, Taiwan -
Mark Collins, PhD, MBA Principal Consultant
Opus Regulatory, United States -
Barbara J. Fanelli, MSc Associate Adjunct Professor
Temple University School of Pharmacy, United States -
A. Leander Fontaine, MD President
Pharmiceutics, LLC., United States -
Paula Hudson, RPh, RAC Director, Global Labeling
Eli Lilly and Company, United States -
Barbara Lachmann, MD Sole Proprietor
Barbara Lachmann Labeling Consulting, Germany -
Megann Looker Executive Director, Head of Global Labeling
Jazz Pharmaceuticals, United Kingdom -
Rie Matsui, RPh Senior Director, Regional Labeling Head for APAC, International Labeling
Pfizer R&D Japan G.K., Japan -
Gerrit Nijveldt, MS, MSc Global Labeling Consultant
Opus Regulatory Inc., United States